Total Funding
86
54
Total FundingSeed raised
Growth Score 86 in past quarter
-8 pts
Heat Score 54 in past quarter
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
63598
STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient and practical manner.
Sadettin Ozturk: Chief Technology OfficerPast Role: MassBiologics, Deputy Director (SVP), Process and Analytical Development- Jonathan Thon: FounderPast Role: mDETECT Inc, Founder and CEO
About the Company
STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient, safe, and practical manner. STRM.BIO aims to fulfill the promise of gene therapy by using extracellular vesicles to deliver treatment directly to the patient. The natural carriers of nucleic acids and proteins with innate targeting
capabilities, the ability to be mass-produced on a large scale commercially, and low immunogenicity.